Cargando…

CD38 promotes angiotensin II‐induced cardiac hypertrophy

Cardiac hypertrophy is an early hallmark during the clinical course of heart failure and regulated by various signalling pathways. Recently, we observed that mouse embryonic fibroblasts from CD38 knockout mice were significantly resistant to oxidative stress such as H(2)O(2)‐induced injury and hypox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Xiao‐Hui, Hong, Xuan, Zhao, Ning, Liu, Xiao‐Hong, Xiao, Yun‐Fei, Chen, Ting‐Tao, Deng, Li‐Bin, Wang, Xiao‐Lei, Wang, Jian‐Bin, Ji, Guang‐Ju, Fu, Mingui, Deng, Ke‐Yu, Xin, Hong‐Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542907/ https://www.ncbi.nlm.nih.gov/pubmed/28296029 http://dx.doi.org/10.1111/jcmm.13076

Ejemplares similares

CD38 Deficiency Protects the Heart from Ischemia/Reperfusion Injury through Activating SIRT1/FOXOs-Mediated Antioxidative Stress Pathway
por: Guan, Xiao-Hui, et al.
Publicado: (2016)

CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway
por: Wang, Ling‐Fang, et al.
Publicado: (2017)

Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats
por: Dai, You-Jin, et al.
Publicado: (2019)

CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis
por: Wang, Ling-Fang, et al.
Publicado: (2023)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Angiotensin‐Converting Enzyme 3 (ACE3) Protects Against Pressure Overload‐Induced Cardiac Hypertrophy
por: Yu, Chang‐Jiang, et al.
Publicado: (2016)

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy
por: Liu, Bei-Lei, et al.
Publicado: (2018)

FKBP12.6 protects heart from AngII‐induced hypertrophy through inhibiting Ca(2+)/calmodulin‐mediated signalling pathways in vivo and in vitro
por: Xiao, Yun‐Fei, et al.
Publicado: (2018)

CD38 Deficiency Alleviates D-Galactose-Induced Myocardial Cell Senescence Through NAD(+)/Sirt1 Signaling Pathway
por: Wang, Ling-Fang, et al.
Publicado: (2019)

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
por: Bhullar, Sukhwinder K., et al.
Publicado: (2022)

Placental extract suppresses cardiac hypertrophy and fibrosis in an angiotensin II-induced cachexia model in mice
por: Yamauchi, Akihiro, et al.
Publicado: (2019)

p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
por: Dai, Hai-long, et al.
Publicado: (2016)

The orphan receptor TR3 participates in angiotensin II-induced cardiac hypertrophy by controlling mTOR signalling
por: Wang, Rong-Hao, et al.
Publicado: (2013)

DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy
por: Zhang, Min-Yu, et al.
Publicado: (2017)

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis
por: Liu, Canzhang, et al.
Publicado: (2023)

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy
por: Yang, Yi, et al.
Publicado: (2023)

Hydroxysafflor yellow A protects against angiotensin II-induced hypertrophy
por: Ni, Bin, et al.
Publicado: (2018)

Upregulation of M(3) muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II
por: Liu, Yan, et al.
Publicado: (2013)

Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation
por: Jiang, Mei-Xiu, et al.
Publicado: (2017)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
por: Yang, Hui, et al.
Publicado: (2020)

Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition
por: Qian, Ling-Bo, et al.
Publicado: (2017)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model
por: Alanazi, Wael A., et al.
Publicado: (2022)

Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice
por: Ren, Kai-Wen, et al.
Publicado: (2022)

Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways
por: Xu, Jia-jia, et al.
Publicado: (2021)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

DIOL Triterpenes Block Profibrotic Effects of Angiotensin II and Protect from Cardiac Hypertrophy
por: Martín, Ruben, et al.
Publicado: (2012)

Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
por: Matsumoto, Emi, et al.
Publicado: (2013)

The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016)

Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy
por: Feng, Yumei, et al.
Publicado: (2012)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways
por: ZHOU, HENG, et al.
Publicado: (2014)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism
por: Li, Jian-Chun, et al.
Publicado: (2023)

Angiotensin-(1-7) attenuates hypertension and cardiac hypertrophy via modulation of nitric oxide and neurotransmitter levels in the paraventricular nucleus in salt-sensitive hypertensive rats
por: Liang, Bin, et al.
Publicado: (2018)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bc22q3ufdhrmj8n242cu4k1rsb